Hubbry Logo
Seasonal affective disorderSeasonal affective disorderMain
Open search
Seasonal affective disorder
Community hub
Seasonal affective disorder
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something
Seasonal affective disorder
Seasonal affective disorder
Seasonal affective disorder
View on Wikipedia
from Wikipedia

Seasonal affective disorder
Other namesSeasonal mood disorder, depressive disorder with seasonal pattern, winter depression, winter blues, January blues, summer depression, seasonal depression
Bright light therapy is a common treatment for seasonal affective disorder and for circadian rhythm sleep disorders.
SpecialtyPsychiatry

Seasonal affective disorder (SAD) is a mood disorder subset in which people who typically have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year.[1][2] It is commonly, but not always, associated with the reductions or increases in total daily sunlight hours that occur during the winter or summer.

Common symptoms include sleeping too much, having little to no energy, and overeating.[3] The condition in the summer can include heightened anxiety.[4] However, there are significant differences in the duration, severity, and symptoms of each individual's experience of SAD. For instance, in a fifth of patients, the disorder completely resolves in five to eleven years, whereas for 33–44% of patients, it progresses into non-seasonal major depression.[5]

In the DSM-IV and DSM-5, its status as a standalone condition was changed: It is no longer classified as a unique mood disorder but is now a specifier (called "with seasonal pattern") for recurrent major depressive disorder that occurs at a specific time of the year and fully remits otherwise.[6] Although experts were initially skeptical, the condition eventually became recognized as a common disorder.[7][additional citation(s) needed] However, the validity of SAD was called into question by a 2016 analysis from the Centers for Disease Control, when it found no links between depression, seasonality or sunlight exposure.[8]

In the United States, the percentage of the population affected by SAD ranges from 1.4% of the population in Florida to 9.9% in Alaska.[9]

Signs and symptoms

[edit]
Video explanation

SAD is a type of major depressive disorder, and those with the condition may exhibit any of the associated symptoms, such as feelings of hopelessness and worthlessness, thoughts of suicide, loss of interest in activities, withdrawal from social interaction, sleep and appetite problems, difficulty with concentrating and making decisions, decreased libido, a lack of energy, or agitation.[4] Symptoms of winter SAD often include falling asleep earlier or in less than 5 minutes in the evening, oversleeping or difficulty waking up in the morning, nausea, and a tendency to overeat, often with a craving for carbohydrates, which leads to weight gain.[10] SAD is typically associated with winter depression, but springtime lethargy or other seasonal mood patterns are not uncommon.[11] Although each individual case is different, in contrast to winter SAD, people who experience spring and summer depression may be more likely to show symptoms such as insomnia, decreased appetite and weight loss, and agitation or anxiety.[4]

Bipolar disorder

[edit]

With seasonal pattern is a specifier for bipolar and related disorders, including bipolar I disorder and bipolar II disorder.[6] Most people with SAD experience major depressive disorder, but as many as 20% may have a bipolar disorder. Bipolar disorder is characterized by alternating episodes of depression and mania or hypomania. Depressive episodes include symptoms such as low energy, difficulty concentrating, changes in sleep and appetite, feelings of hopelessness, and suicidal thoughts. Manic episodes, which are more common in bipolar I disorder, may include elevated mood, decreased need for sleep, impulsivity, and increased activity or risky behaviors. In contrast, hypomania (seen in bipolar II disorder) presents as a milder form of mania without significant impairment in daily life.[12] It is important to distinguish between diagnoses because there are important treatment differences.[13] In these cases, people who have the With seasonal pattern specifier may experience a depressive episode either due to major depressive disorder or as part of bipolar disorder during the winter and remit in the summer.[6] Around 25% of patients with bipolar disorder may present with a depressive seasonal pattern, which is associated with bipolar II disorder, rapid cycling, eating disorders, and more depressive episodes.[14] Differences in biological sex display distinct clinical characteristics associated to seasonal pattern: males present with more Bipolar II disorder and a higher number of depressive episodes, and females with rapid cycling and eating disorders.[14]

ADHD

[edit]

A study by the National Institute of Health published findings in 2016 that concluded, "seasonal and circadian rhythm disturbances are significantly associated with ADHD symptoms." Participants in the study who had ADHD were three times more likely to have SAD symptoms (9.9% vs 3.3%), and about 2.7 times more likely to have s-SAD symptoms (12.5% vs 4.6%).[15] Those with ADHD and SAD are likely to experience sluggishness, irritability, and withdrawal.[16] A study published in the Journal of Affective Disorders found that approximately 27% of adults with ADHD also experience SAD, with women being more susceptible than men.[17]

Cause

[edit]

In many species, activity is diminished during the winter months, in response to the reduction in available food, the reduction of sunlight (especially for diurnal animals), and the difficulties of surviving in cold weather. Hibernation is an extreme example, but even species that do not hibernate often exhibit changes in behavior during the winter.[18]

Various proximate causes have been proposed. One possibility is that SAD is related to a lack of serotonin, and serotonin polymorphisms could play a role in SAD,[19] although this has been disputed.[20] Mice incapable of turning serotonin into N-acetylserotonin (by serotonin N-acetyltransferase) appear to express "depression-like" behavior, and antidepressants such as fluoxetine increase the amount of the enzyme serotonin N-acetyltransferase, resulting in an antidepressant-like effect.[21] Another theory is that the cause may be related to melatonin, which is produced in dim light and darkness by the pineal gland,[22] since there are direct connections, via the retinohypothalamic tract and the suprachiasmatic nucleus, between the retina and the pineal gland.[23][citation needed] Melatonin secretion is controlled by the endogenous circadian clock, but can also be suppressed by bright light.[22]

One study looked at whether some people could be predisposed to SAD based on personality traits. Correlations between certain personality traits such as higher levels of neuroticism, agreeableness, openness, and an avoidance-oriented coping style, appeared to be common in those with SAD.[1]

Per Pfizer, risk factors for SAD include being a female, younger age, previously being diagnosed with extreme depression or bipolar disorder, having a family history of the same disease, or living a considerable distance from the equator.[24]

Pathophysiology

[edit]

Seasonal mood variations are believed to be related to light. An argument for this view is the effectiveness of bright-light therapy.[25] SAD is measurably present at latitudes in the Arctic region, such as northern Finland (around 64 degrees north latitude), where the rate of SAD is 9.5%.[26] Cloud cover may contribute to the negative effects of SAD.[27] There is evidence that many patients with SAD have a delay in their circadian rhythm, and that bright light treatment corrects these delays which may be responsible for the improvement in patients.[22]

The symptoms of it mimic those of dysthymia or even major depressive disorder. There is also potential risk of suicide in some patients experiencing SAD. One study reports 6–35% of people with the condition required hospitalization during one period of illness.[27] At times, patients may not feel depressed, but rather lack energy to perform everyday activities.[25]

Subsyndromal Seasonal Affective Disorder (s-SAD or SSAD) is a milder form of SAD experienced by an estimated 14.3% (vs. 6.1% SAD) of the U.S. population.[28] The blue feeling experienced by both those with SAD and with SSAD can usually be dampened or extinguished by exercise and increased outdoor activity, particularly on sunny days, resulting in increased solar exposure.[29] Connections between human mood, as well as energy levels, and the seasons are well documented, even in healthy individuals.[30]

Diagnosis

[edit]

According to the American Psychiatric Association DSM-IV criteria,[31] Seasonal Affective Disorder is not regarded as a separate disorder. It is called a "course specifier" and may be applied as an added description to the pattern of major depressive episodes in patients with major depressive disorder or patients with bipolar disorder.

The "Seasonal Pattern Specifier" must meet four criteria: depressive episodes at a particular time of the year; remissions or mania/hypomania at a characteristic time of year; these patterns must have lasted two years with no nonseasonal major depressive episodes during that same period; and these seasonal depressive episodes outnumber other depressive episodes throughout the patient's lifetime. The Mayo Clinic describes three types of SAD, each with its own set of symptoms.[4]

Management

[edit]
See also: Occupational therapy in the management of seasonal affective disorder

Treatments for classic (winter-based) seasonal affective disorder include light therapy, medication, cognitive-behavioral therapy, and carefully timed supplementation[32] of the hormone melatonin.[33]

Light therapy

[edit]

Photoperiod-related alterations of the duration of melatonin secretion may affect the seasonal mood cycles of SAD. This suggests that light therapy may be an effective treatment for SAD.[34] Light therapy uses a lightbox, which emits far more lumens than a customary incandescent lamp. Bright white "full spectrum" light at 10,000 lux, blue light at a wavelength of 480nm at 2,500 lux or green (actually cyan or blue-green[35]) light at a wavelength of 500nm at 350 lux are used, with the first-mentioned historically preferred.[36][37]

Bright light therapy is effective[28] with the patient sitting a prescribed distance, commonly 30–60 cm, in front of the box with their eyes open, but not staring at the light source,[26] for 30–60 minutes. A study published in May 2010 suggests that the blue light often used for SAD treatment should perhaps be replaced by green or white illumination.[38] Discovering the best schedule is essential. One study has shown that up to 69% of patients find lightbox treatment inconvenient, and as many as 19% stop use because of this.[26]

Dawn simulation has also proven to be effective; in some studies, there is an 83% better response when compared to other bright light therapy.[26] When compared in a study to negative air ionization, bright light was shown to be 57% effective vs. dawn simulation 50%.[39] Patients using light therapy can experience improvement during the first week, but increased results are evident when continued throughout several weeks.[26] Certain symptoms like hypersomnia, early insomnia, social withdrawal, and anxiety resolve more rapidly with light therapy than with cognitive behavioral therapy.[40] Most studies have found it effective without use year round, but rather as a seasonal treatment lasting for several weeks, until frequent light exposure is naturally obtained.[25]

Light therapy can also consist of exposure to sunlight, either by spending more time outside[41] or using a computer-controlled heliostat to reflect sunlight into the windows of a home or office.[42][43] Although light therapy is the leading treatment for seasonal affective disorder, prolonged direct sunlight or artificial lights that don't block the ultraviolet range should be avoided, due to the threat of skin cancer.[44]

The evidence base for light therapy as a preventive treatment for seasonal affective disorder is limited.[45] The decision to use light therapy to treat people with a history of winter depression before depressive symptoms begin should be based on a person's preference of treatment.[45]

Medication

[edit]

SSRI (selective serotonin reuptake inhibitor) antidepressants have proven effective in treating SAD.[27] Effective antidepressants are fluoxetine, sertraline, or paroxetine.[25][46] Both fluoxetine and light therapy are 67% effective in treating SAD, according to direct head-to-head trials conducted during the 2006 Can-SAD study.[47] Subjects using the light therapy protocol showed earlier clinical improvement, generally within one week of beginning the clinical treatment.[25] Bupropion extended-release has been shown to prevent SAD for one in four people, but has not been compared directly to other preventive options in trials.[48] In a 2021 updated Cochrane review of second-generation antidepressant medications for the treatment of SAD, a definitive conclusion could not be drawn, due to lack of evidence, and the need for larger randomized controlled trials.[49]

Modafinil may be an effective and well-tolerated treatment in patients with seasonal affective disorder/winter depression.[50]

Another explanation is that vitamin D levels are too low when people do not get enough Ultraviolet-B on their skin. An alternative to using bright lights is to take vitamin D supplements.[51][52][53] However, studies did not show a link between vitamin D levels and depressive symptoms in elderly Chinese,[54] nor among elderly British women given only 800IU when 6,000IU is needed.[55] 5-HTP (an amino acid that helps to produce serotonin, and is often used to help those with depression) has also been suggested as a supplement that may help treat the symptoms of SAD, by lifting mood, and regulating sleep schedule for those with the condition.[56] However, those who take antidepressants are not advised to take 5-HTP, as antidepressant medications may combine with the supplement to create dangerously high levels of serotonin – potentially resulting in serotonin syndrome.[57]

Other treatments

[edit]

Depending upon the patient, one treatment (e.g., lightbox) may be used in conjunction with another (e.g., medication).[25]

Physical exercise has shown to be an effective form of depression therapy, particularly when in addition to another form of treatment for SAD.[58] One particular study noted marked effectiveness for treatment of depressive symptoms, when combining regular exercise with bright light therapy.[59] Patients exposed to exercise which had been added to their treatments in 20 minutes intervals on the aerobic bike during the day, along with the same amount of time underneath the UV light were seen to make a quick recovery.[60]

Of all the psychological therapies aimed at the prevention of SAD, cognitive-behavior therapy, typically involving thought records, activity schedules and a positive data log, has been the subject of the most empirical work. However, evidence for cognitive behavioral therapy or any of the psychological therapies aimed at preventing SAD remains inconclusive.[61]

Epidemiology

[edit]

Nordic countries

[edit]

Winter depression is a common slump in the mood of some inhabitants of most of the Nordic countries. Iceland, however, seems to be an exception. A study of more than 2000 people there found the prevalence of seasonal affective disorder and seasonal changes in anxiety and depression to be unexpectedly low in both sexes.[62] The study's authors suggested that propensity for SAD may differ due to some genetic factor within the Icelandic population. A study of Canadians of wholly Icelandic descent also showed low levels of SAD.[63] It has more recently been suggested that this may be attributed to the large amount of fish traditionally eaten by Icelandic people. In 2007, about 90 kilograms of fish per person was consumed per year in Iceland, as opposed to about 24 kilograms in the US and Canada,[64] rather than to genetic predisposition; a similar anomaly is noted in Japan, where annual fish consumption in recent years averages about 60 kilograms per capita.[65] Fish are high in vitamin D. Fish also contain docosahexaenoic acid (DHA), which helps with a variety of neurological dysfunctions.[66][dubious – discuss]

Other countries

[edit]

In the United States, a diagnosis of seasonal affective disorder was first proposed by Norman E. Rosenthal, M.D. in 1984. Rosenthal wondered why he became sluggish during the winter after moving from sunny South Africa to (cloudy in winter) New York. He started experimenting with increasing exposure to artificial light, and found this made a difference. In Alaska it has been established that there is a SAD rate of 8.9%, and an even greater rate of 24.9%[67] for subsyndromal SAD.

Around 20% of Irish people are affected by SAD, according to a survey conducted in 2007. The survey also shows women are more likely to be affected by SAD than men.[68][better source needed] An estimated 3% of the population in the Netherlands experience winter SAD.[69]

History

[edit]

SAD was formally described and named in 1984 by Norman E. Rosenthal and his colleagues at the National Institute of Mental Health.[70][71] The initial investigation was motivated by observations of depression occurring during the dark winter months in northern regions of the United States, known as polar night. Rosenthal proposed that the reduction in available natural light during winter could contribute to this phenomenon. Subsequently, he and his colleagues conducted a placebo-controlled study that utilized light therapy to document the effects of the condition.[70][71] Although Rosenthal's ideas were initially greeted with skepticism, SAD has become well recognized. His 1993 book Winter Blues[72] has become the standard introduction to the subject.[73]

Research on SAD in the United States began in 1979 when Herb Kern, a research engineer, noticed he felt depressed during the winter months. Kern suspected that scarcer natural light in winter was the cause and discussed the idea with NIMH scientists working on bodily rhythms. They were intrigued and responded by inventing a lightbox to treat Kern's depression, which improved.[71][74]

SAD is usually more common in the fall/winter (Winter SAD), though it may occur during the spring/summer (Spring SAD). Winter-onset SAD is more common and is often characterized by atypical depressive symptoms including hypersomnia, increased appetite, and craving for carbohydrates. Spring/summer SAD is also seen and is more frequently associated with typical depressive symptoms including insomnia and loss of appetite.[75]

Criticism of disorder and diagnosis

[edit]

The validity of SAD has been called into question multiple times. A 2008 study indicated that some people stay without sun for months, yet they are not affected by SAD.[76] A 2016 analysis from the Centers for Disease Control found no links between depression, seasonality or sunlight exposure and suggested discontinuation of the diagnosis. Further, a 2018 study focusing on instability of SAD diagnosis criteria over prolonged periods of time, suggested that SAD is a temporary expression of a mood disorder rather than a specific disorder.[8][77]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Seasonal affective disorder

View on Grokipedia
from Grokipedia
Seasonal affective disorder (SAD) is a subtype of characterized by recurrent episodes of depression that follow a distinct seasonal pattern, most commonly onsetting in the late fall or and remitting in the spring or early summer. Symptoms typically persist for about four to five months annually, distinguishing SAD from non-seasonal forms of depression. This condition affects an estimated 1.5% to 9% of individuals, with increasing at higher latitudes due to reduced daylight exposure. The core symptoms of SAD mirror those of major depression, including persistent feelings of or hopelessness, loss of interest or pleasure in activities, fatigue or low energy, difficulty concentrating, and thoughts of death or . However, SAD is often marked by atypical features such as (excessive sleeping), hyperphagia (increased , particularly for carbohydrates), and subsequent , which differentiate it from other depressive subtypes. These symptoms can significantly impair daily functioning, work, school performance, and relationships, leading to substantial distress if untreated. The precise of SAD remains unclear, but it is strongly linked to diminished during shorter days, which disrupts the body's and influences levels. Reduced light exposure may disrupt the hypothalamus's regulation of production in the , contributing to mood regulation imbalances, while changes in serotonin activity are also implicated. Risk factors include living farther from the , a or personal or , and being female, as SAD occurs approximately four times more frequently in women than in men, with typical onset between ages 18 and 30. Effective treatments for SAD focus on counteracting the seasonal triggers and alleviating depressive symptoms. , using a high-intensity light box to simulate natural , is a first-line intervention that can improve symptoms within days to weeks by regulating circadian rhythms. , such as adapted for SAD (CBT-SAD), helps individuals manage negative thought patterns and behavioral changes associated with the seasons. medications, including selective serotonin inhibitors (SSRIs), are also commonly prescribed, particularly for moderate to severe cases, often in combination with other therapies. Lifestyle strategies, such as maximizing natural sunlight exposure through increased outdoor time and engaging in regular physical activity, may provide adjunctive support.

Signs and Symptoms

Core Psychological and Physical Symptoms

Seasonal affective disorder (SAD) primarily manifests as a subtype of with a recurrent seasonal pattern, where the core symptoms align with those of depression but exhibit distinct vegetative features. In the more prevalent winter-onset form, individuals experience persistent feelings of sadness, hopelessness, or emptiness that dominate their mood throughout the day. Accompanying psychological symptoms include a marked loss of interest or pleasure in previously enjoyable activities, known as , and increased irritability or anxiety. Physically, and low energy levels are prominent, often leading to difficulty initiating or maintaining daily tasks, alongside (excessive sleeping). Appetite changes are common, characterized by intense cravings for carbohydrates, resulting in and subsequent . Social withdrawal is also typical, as individuals isolate themselves from friends and family, exacerbating feelings of . The less common summer-onset SAD presents with a contrasting symptom profile, often resembling non-seasonal agitation-driven depression. Psychological symptoms may include heightened anxiety, restlessness, and agitation, with persistent low mood and reduced ability to concentrate. Physical manifestations differ notably, featuring or disrupted patterns, decreased leading to , and increased physical agitation rather than . These symptoms typically emerge in late spring or early summer and remit by fall. In both patterns, symptoms generally persist for 4 to 5 months annually, beginning in late fall for winter-onset cases and resolving by spring or summer, or vice versa for summer-onset. This cyclical nature disrupts daily functioning profoundly, impairing work or academic performance through diminished concentration and productivity, straining relationships due to withdrawal and , and hindering self-care routines such as maintaining or . For instance, individuals may struggle to meet professional deadlines or engage in social events, leading to broader life interference.

Comorbidities and Overlapping Conditions

Seasonal affective disorder (SAD) frequently co-occurs with , where it may manifest as a seasonal variant characterized by recurrent winter depressive episodes followed by spring/summer or . Approximately 25% of individuals with exhibit a depressive seasonal pattern, and up to 15% meet criteria for comorbid SAD. This overlap is notable because , a primary treatment for SAD, carries a risk of inducing manic or hypomanic switches in bipolar patients with seasonal patterns, with reported rates as high as 4% under clinical supervision. SAD also shows associations with attention-deficit/hyperactivity disorder (ADHD). In clinical populations of adults with ADHD, the prevalence of SAD reaches about 27%, with females at higher risk, suggesting potential misdiagnosis when seasonal mood dips are attributed solely to ADHD core traits. Anxiety disorders commonly coexist with SAD, complicating diagnosis due to overlapping , though anxiety is not inherently more prevalent in SAD than in non-seasonal depression; its presence often correlates with greater overall symptom severity. High rates of comorbid and have been observed in cohorts with recurrent seasonal major depressive episodes. Bulimia nervosa exhibits seasonal patterns akin to SAD, with elevated binge-eating behaviors in winter among SAD patients, extending beyond typical hyperphagia to full pathology. Similarly, chronic fatigue syndrome shares symptom overlaps with SAD, such as persistent fatigue and , occasionally leading to SAD being misidentified as chronic fatigue in winter presentations.

Causes and Pathophysiology

Environmental and Seasonal Triggers

Seasonal affective disorder (SAD) is primarily triggered by changes in environmental light exposure associated with seasonal variations, particularly the reduction in during winter months. This reduction in sunlight can trigger or exacerbate depression in susceptible individuals via SAD, a subtype of major depression characterized by symptoms such as sadness, fatigue, hypersomnia, increased appetite, and social withdrawal. Effects may be more intense for individuals originating from sunnier climates who relocate to regions with pronounced seasonal light variations, due to abrupt disruptions in light exposure patterns. In regions with shorter daylight hours and less intense , such as those at higher latitudes, individuals experience diminished , which coincides with the onset of depressive episodes in late fall or early winter. This pattern is most evident in winter-onset SAD, which accounts for the majority of cases, with symptoms typically remitting in spring as daylight increases. Winter-type SAD predominates, comprising approximately 90% of diagnosed cases, while summer-type SAD, affecting about 10% of individuals with the disorder, is linked to environmental factors like prolonged , high , and increased exposure during warmer months. These summer triggers can exacerbate mood disturbances through discomfort from overheating and disrupted due to extended daylight or poor air quality from and pollutants. Geographic location plays a key role, with higher incidence rates observed in northern latitudes where extreme seasonal light variations—such as prolonged darkness in winter—intensify the condition compared to equatorial regions. These interactions are more pronounced in low-light areas, where reduced daylight and low temperatures compound effects on sleepiness and fatigue. Additional environmental factors include modern indoor lifestyles that further limit exposure, as people spend more time indoors during colder, darker seasons, compounding the effects of reduced outdoor daylight. Low temperatures in winter increase energy demands for thermoregulation, promoting energy conservation behaviors that may manifest as increased sleepiness, akin to evolutionary remnants of hibernation in early humans who slowed metabolism during harsh winters to survive. across time zones can also precipitate disruptions by altering exposure to local light cycles, mimicking or intensifying seasonal shifts for susceptible individuals. In severe cases, pronounced winter sleepiness may indicate underlying SAD.

Neurobiological and Genetic Mechanisms

The serotonin hypothesis posits that reduced exposure to sunlight in winter leads to diminished serotonin levels in the , thereby impairing mood and contributing to depressive symptoms in seasonal affective disorder (SAD), including low energy and fatigue. Low sunlight exposure may also contribute to , as the skin produces in response to ultraviolet B rays; this deficiency has been associated with reduced serotonin synthesis and increased risk of depressive symptoms in SAD. Studies have shown that individuals with winter-pattern SAD exhibit lower serotonin activity, as measured by reduced uptake of a serotonin precursor in , compared to healthy controls. This dysfunction is thought to arise from decreased stimulating serotonin synthesis via retinal pathways, exacerbating symptoms like low mood and carbohydrate craving. Melatonin dysregulation represents another key mechanism, where shorter winter days result in prolonged nocturnal secretion that extends even into daytime due to insufficient light suppression, disrupting sleep-wake cycles and promoting in SAD patients. Research indicates that this extended production, regulated by the , fails to suppress adequately during the day due to insufficient , leading to altered circadian signaling and . In susceptible individuals, this imbalance correlates with phase delays in the offset time, further linking it to mood disturbances. Circadian rhythm models emphasize phase shifts in the internal biological clock as a core feature of SAD pathophysiology, with the (SCN) in the serving as the primary pacemaker that synchronizes daily rhythms to cues. The phase-shift hypothesis suggests that in winter, the delays relative to the sleep-wake cycle due to early sunsets and dark mornings, causing a misalignment that manifests as depression; this is evidenced by later dim melatonin onset in SAD patients during short days. SCN involvement is highlighted by its role in integrating photic input from the , where disruptions lead to desynchronized hormonal and behavioral outputs, amplifying affective symptoms. Genetic factors contribute significantly to SAD vulnerability, with heritability estimates ranging from 29% to 45% based on twin studies examining seasonal mood variations. Polymorphisms in clock genes, such as PER2 and CLOCK, have been associated with increased risk; for instance, variants in PER2 disrupt circadian timing, while CLOCK mutations influence seasonal symptom severity in affected cohorts. These genetic alterations likely interact with environmental light changes to heighten susceptibility, as seen in patterns where first-degree relatives of SAD patients show elevated scores. Recent research from 2023 to 2025 has advanced understanding through studies on sensitivity to and longitudinal cohort analyses of - interactions. Investigations using pupillometry have demonstrated heightened responsivity to blue light in SAD patients post-light exposure, correlating with reduced depressive symptoms and suggesting intrinsically photosensitive cells (ipRGCs) as a modulator of mood via direct SCN projections. Large-scale cohort tracking, such as analyses, reveals that interactions between duration and daily exposure predict SAD onset, with individuals showing delayed circadian phases in winter exhibiting poorer - alignment and heightened risk. These findings underscore how individual variability in processing and influences biological responses to seasonal changes.

Diagnosis and Assessment

Diagnostic Criteria

Seasonal affective disorder (SAD) is diagnosed as a specifier applied to recurrent or in the DSM-5-TR, requiring a pattern of major depressive episodes that demonstrate a temporal relationship to a particular season. The essential criteria include the presence of major depressive episodes that occur at a specific time of year, typically fall or winter, with full remissions or return to near-normal mental status during the opposite season; this seasonal pattern must have been present for at least two consecutive years, and seasonal episodes must substantially outnumber any nonseasonal depressive episodes in the individual's history. Additionally, the temporal relationship between episode onset and the season must not be better explained by other or seasonal factors, such as seasonal . The DSM-5-TR recognizes two primary subtypes based on the seasonal timing: the winter pattern, characterized by episodes beginning in late fall or winter and remitting by spring or summer, and the less common summer pattern, with onset in late spring or summer and remission in fall or winter. For the winter subtype, associated features often include atypical depressive symptoms such as and increased appetite, while the summer subtype may involve more typical symptoms like and , though these are not required for the specifier. In the , SAD is classified under recurrent depressive disorder (6A71) or bipolar disorders with the postcoordinated qualifier 6A80.4 for seasonal pattern of mood episode onset. This qualifier applies when there is a regular temporal relationship between the onset of at least two mood episodes and a particular period of the year (e.g., autumn or winter), with seasonal episodes substantially outnumbering nonseasonal ones; full remissions must occur outside the seasonal period, and the pattern should persist for more than two years without predominance of nonseasonal episodes. The does not specify subtypes but allows the seasonal qualifier for both depressive and bipolar mood disorders, emphasizing the recurrent nature and exclusion of explanations attributable to seasonal situational factors.

Differential Diagnosis and Screening Tools

Differentiating seasonal affective disorder (SAD) from other conditions is essential, as its symptoms overlap significantly with several psychiatric and medical disorders. Common differentials include non-seasonal (MDD), which presents with persistent low mood, , and fatigue but lacks the predictable seasonal onset and remission characteristic of SAD. may mimic SAD through symptoms such as lethargy, weight gain, and cognitive slowing, necessitating to rule it out. can contribute to depressive symptoms and fatigue, particularly in winter months due to reduced sunlight exposure, and should be assessed via serum levels. Sleep disorders, including disruptions or not tied to seasons, also require consideration, as they can exacerbate mood disturbances without the temporal pattern seen in SAD. Screening tools play a key role in identifying potential SAD cases for further evaluation. The Seasonal Pattern Assessment Questionnaire (SPAQ) is a widely used self-report instrument that assesses changes in mood, , , , and social activity across seasons, yielding a Global Seasonality Score to gauge the degree of . It demonstrates good specificity (94%) but lower sensitivity (44%), making it suitable as a screening rather than diagnostic tool. The Guide for the Hamilton Depression Rating Scale – Seasonal Affective Disorders version (SIGH-SAD) extends the standard Hamilton Depression Rating Scale by adding items for atypical symptoms like and carbohydrate craving, providing a structured clinician-administered assessment of depression severity in a seasonal context. Validation studies confirm its reliability for monitoring SAD symptoms, with scores ranging from 0 to 90. Clinical evaluation involves a detailed focusing on the timing of symptom onset and remission, typically aligning with shorter daylight periods, alongside into responses to previous seasons and family of mood disorders. Laboratory tests, such as thyroid-stimulating hormone (TSH) levels, help exclude hypothyroidism, as elevated TSH has been observed in some SAD patients but requires differentiation from primary thyroid dysfunction. Additional workup may include vitamin D assays and sleep studies if indicated, ensuring other organic causes are ruled out before confirming the DSM-5 seasonal specifier for major depressive disorder. Challenges in SAD diagnosis include underdiagnosis, particularly in mild cases where symptoms are attributed to "winter blues" rather than a clinical disorder, leading to delayed intervention. Cultural variations further complicate assessment, as individualism-collectivism dimensions influence symptom reporting and seasonal mood sensitivity; for instance, higher individualism correlates with increased winter-SAD prevalence relative to summer patterns. These factors underscore the need for culturally sensitive screening and clinician awareness to improve detection rates.

Treatment and Management

Light Therapy

Light therapy serves as the primary non-pharmacological intervention for seasonal affective disorder (SAD), primarily through the use of bright light boxes that emit approximately 10,000 of illumination to replicate the intensity of natural , thereby suppressing production and advancing circadian rhythms disrupted during winter months. This exposure helps alleviate core symptoms by influencing the in the , which regulates sleep-wake cycles and mood-related neurotransmitters like serotonin. An alternative approach, dawn simulation, employs a device that gradually increases light intensity over 30-60 minutes upon awakening, mimicking sunrise to gently reset the internal clock and improve morning alertness without the need for sustained high-intensity exposure. Standard protocols recommend daily sessions of 30-60 minutes, ideally starting upon waking and positioned 16-24 inches from the face while keeping eyes open but not staring directly at the light source, to ensure effective . Timing is crucial, with morning administration preferred to align with circadian phase advances in SAD patients; adjustments may involve advancing exposure earlier by 1-2 hours if symptoms persist, based on individual assessments. Treatment typically begins in early fall and continues through spring, with gradual tapering to prevent relapse, and devices must filter rays to minimize risks. Clinical trials demonstrate efficacy rates of 60-80% in reducing depressive symptoms, with noticeable improvements often emerging within 1-2 weeks—faster than the typical 4-6 weeks required for antidepressants—making it a first-line option for mild to moderate SAD. This rapid onset is attributed to direct modulation of circadian disruptions underlying the disorder. Common side effects are mild and transient, including , headaches, and occasional , affecting fewer than 20% of users and usually resolving with dosage adjustments. However, it is contraindicated in individuals with due to the risk of inducing or , necessitating medical supervision in such cases. Recent studies from 2024-2025 have reinforced these benefits, showing that consistent bright exposure, tracked via wearable devices, enhances sleep regularity and mood stabilization in SAD patients by increasing daytime dose and reducing nocturnal disruptions. For instance, a 2025 trial using optimized protocols with real-time exposure monitoring reported improved and sustained mood gains persisting up to six months post-treatment. These findings underscore therapy's role in personalized interventions, particularly for those with variable compliance.

Pharmacological and Psychotherapy Options

Pharmacological treatments for seasonal affective disorder (SAD) primarily involve selective serotonin reuptake inhibitors (SSRIs) and certain other antidepressants, with bupropion extended-release (XL) being the only medication specifically FDA-approved for preventing major depressive episodes in individuals with a history of SAD. Bupropion XL is typically initiated prophylactically in the autumn before symptoms emerge, starting at 150 mg once daily for one week and increasing to a target dose of 300 mg once daily in the morning to minimize risk. For acute treatment, SSRIs such as (20 mg daily) have demonstrated efficacy comparable to , with response rates around 50-60% in clinical trials. Sertraline is another commonly studied SSRI, showing similar in reducing depressive symptoms during winter months. These medications are often tapered or discontinued in spring to align with seasonal symptom remission, though monitoring for withdrawal is essential. Cognitive behavioral therapy adapted for SAD (CBT-SAD) represents a key psychotherapeutic option, consisting of 12 structured sessions delivered twice weekly over six weeks, emphasizing the identification and restructuring of negative automatic thoughts related to winter and to counteract seasonal inactivity. CBT-SAD has been shown to be as effective as in alleviating acute SAD symptoms, with remission rates of approximately 50% post-treatment. Unlike , CBT-SAD offers longer-term benefits, including a reduced risk of relapse in subsequent winters by equipping patients with coping strategies for seasonal triggers. In patients with comorbid , both SSRIs and CBT-SAD require careful monitoring to mitigate risks of mood destabilization. Efficacy comparisons indicate that SSRIs and CBT-SAD yield similar short-term response rates of 50-60%, but CBT-SAD may confer superior relapse prevention, with studies showing lower recurrence rates (around 25-40%) over 1-2 years compared to medication alone. For severe cases, combining with has emerging evidence of enhanced outcomes, such as faster symptom resolution and higher remission rates (up to 70% in some trials), particularly when SSRIs like are paired with morning light exposure. Recent evidence from 2023-2024 underscores the value of seasonal SSRI use, with a 2024 review affirming their role in prevention and noting persistent challenges in treatment access, as highlighted in discussions on equitable care for mood disorders.

Lifestyle and Alternative Interventions

Lifestyle modifications play a supportive role in managing seasonal affective disorder (SAD) by addressing environmental and behavioral factors that exacerbate symptoms. Regular physical exercise, particularly aerobic activities such as walking, jogging, or yoga, preferably performed outdoors, has been shown to alleviate depressive symptoms in individuals with SAD through mechanisms like increased serotonin production, boosted endorphins, improved mood, increased energy, and enhanced sleep regulation. A 2024 systematic review identified exercise as a promising but understudied intervention for SAD, with small studies (n=9) showing significant symptom reductions of around 68% on depression scales after one week of daily one-hour sessions, though evidence quality is very low due to methodological limitations. As of 2025, guidelines from the recommend exercise as an adjunct to primary treatments like , with moderate evidence supporting its role in symptom alleviation when combined with other interventions. Spending time outdoors, especially during morning daylight hours, even on overcast days, enhances natural light exposure to help regulate circadian rhythms and promotes vitamin D synthesis, which can mitigate mood dips, low energy, and fatigue associated with reduced daylight. Dietary adjustments are another accessible strategy, focusing on balanced nutrition to counteract carbohydrate cravings often linked to SAD. Emphasizing proteins (e.g., , eggs, and ), complex carbohydrates, and omega-3 fatty acids (found in fatty fish and certain plant sources) while limiting refined sugars helps stabilize blood sugar and boost levels like serotonin. Research indicates that such dietary patterns, combined with mindfulness around eating habits, contribute to modest improvements in energy and mood during winter months. Other supportive measures include maintaining consistent sleep patterns to reinforce circadian alignment and staying socially active to reduce isolation and support emotional well-being. Alternative interventions include supplementation for those with confirmed deficiencies, as lower exposure in winter correlates with reduced levels and worsened SAD symptoms. Adequate vitamin D levels can also be maintained through safe sun exposure and consumption of vitamin D-rich foods (e.g., fatty fish, fortified foods). Clinical guidelines recommend testing serum levels before supplementation, with doses of 1,000-2,000 IU daily showing potential benefits in small s, though evidence remains preliminary. Consultation with a healthcare provider is recommended for testing and appropriate dosing. Negative air , delivered via high-density ion generators, has demonstrated effects in controlled studies, improving atypical SAD symptoms like and overeating without notable side effects. A double-blind found that 2.7 × 10^6 ions/cm³ exposure for one hour daily led to significant symptom reduction comparable to in some participants. Herbal options like St. John's wort have limited and conflicting evidence for SAD specifically, with early studies suggesting mild benefits but recent meta-analyses indicating no superiority over for moderate depression. Preventive strategies emphasize proactive measures to anticipate seasonal onset. Gradually increasing outdoor time in late autumn can help maintain circadian rhythms and preempt symptom escalation. For those with severe winter-pattern SAD, short-term travel to sunnier climates has been recommended as a feasible option to interrupt the cycle of reduced light exposure, with anecdotal and observational support from clinical practice. Recent 2025 research highlights the mitigating role of against seasonal depression, showing that higher daily step counts (e.g., 10,000+) during colder months inversely correlate with depression severity, influenced by but buffered by consistent movement.

Epidemiology

Prevalence and Geographic Variations

Seasonal affective disorder (SAD) affects an estimated 0.5% to 10% of the global population, with winter-onset SAD comprising approximately 75% to 80% of cases. A 2023 systematic review and reported a pooled global of 5.01% for SAD and 0.57% for summer-onset SAD, highlighting the predominance of the winter form. These estimates vary widely due to diagnostic criteria and study methodologies, but they underscore SAD as a notable contributor to seasonal mood disruptions worldwide. Prevalence exhibits a clear latitude gradient, with rates increasing toward higher northern s where reduced daylight exposure is more pronounced. In such as and , studies indicate rates of 8% to 10% for SAD in certain populations, compared to less than 1% in equatorial regions. The same 2023 meta-analysis confirmed this pattern, finding that SAD prevalence rises by 0.2% and subsyndromal SAD (S-SAD) by 0.32% for each 1-degree increase in . For instance, northern (around 64°N) reports a SAD rate of 9.5%, while rates in southern U.S. states like are as low as 1.4%. Recent data from 2024 reinforces these trends in the United States, where an poll found that 5% of adults experience SAD, often lasting about 40% of the year, and 41% report a general mood decline in winter. This aligns with the latitude-linked findings from the 2023 meta-analysis, which provides quantitative evidence of higher SAD and S-SAD rates in temperate and polar zones. Subsyndromal SAD (S-SAD), a milder form characterized by seasonal mood changes without full diagnostic criteria for major depression, has an estimated global prevalence of 9.37%, with elevated rates in higher-latitude areas similar to full SAD. These cases often involve subsyndromal symptoms tied to seasonal light reductions, contributing to broader seasonal sensitivity in affected regions.

Demographic and Risk Factor Patterns

Seasonal affective disorder (SAD) exhibits distinct demographic patterns, with women being affected two to four times more frequently than men, a disparity observed across multiple studies. This difference may relate to hormonal or biological factors, though the exact mechanisms remain under investigation. The condition typically emerges in early adulthood, with the peak age of onset occurring between 20 and 30 years, and it is rare in individuals under 20, though risk may increase with advancing age in later life. Key risk factors for SAD include a family history of the disorder or other forms of depression, suggesting a that heightens vulnerability. Individuals with a personal history of or are also at elevated risk, as these conditions can recur or intensify seasonally. Pre-existing anxiety disorders further compound susceptibility, often co-occurring with SAD and exacerbating symptoms during periods of reduced sunlight. Patterns of SAD also vary by residential and socioeconomic contexts. Recent surveys indicate that rural residents report higher rates of winter mood decline associated with SAD symptoms compared to urban dwellers, potentially due to differences in light exposure and lifestyle factors. Regarding , epidemiological in urban settings has found SAD to be more prevalent among those in higher socioeconomic groups, distinguishing it from non-seasonal depression, which correlates with deprivation; lower may indirectly influence risk through barriers to accessing or outdoor activities. Recent 2025 cohort studies have linked disrupted patterns and reduced levels to increased SAD vulnerability, while data from Thriveworks analysis highlights symptom peaks in the third week of November, underscoring the role of behavioral rhythms in risk profiles. Additionally, individuals relocating from sunnier climates to higher-latitude regions with longer winters may experience more intense SAD effects due to abrupt changes in light exposure, as evidenced by research on immigrant populations and aligning with observed geographic variations in prevalence.

History and Research

Historical Development

Early observations of seasonal patterns in mood disturbances date back to the , when French psychiatrist Jean-Étienne Dominique Esquirol documented cases of recurrent depression that aligned with winter months. In 1825, Esquirol described a Belgian merchant whose depressive episodes intensified during autumn and winter, recommending therapeutic vacations to sunnier regions in and to alleviate symptoms, marking one of the first anecdotal links between reduced and mood decline. By the 1840s, Esquirol's works further emphasized the potential benefits of light exposure for such seasonal , influencing early psychiatric thought on environmental factors in . The modern recognition of seasonal affective disorder (SAD) emerged in the early 1980s through research at the (NIMH) led by psychiatrist Norman E. Rosenthal. Rosenthal, who experienced seasonal mood changes himself after moving from sunny to the , hypothesized a connection between diminished winter daylight and recurrent depression. In a seminal 1984 paper, Rosenthal and colleagues formally described SAD as a distinct syndrome involving annual winter depressive episodes followed by spring-summer remissions, based on clinical observations of affected individuals. Key milestones in the solidified SAD's status as a clinical entity. The disorder transitioned from colloquial "winter blues" to a recognized medical condition with the publication of initial studies demonstrating its prevalence and treatability. In 1987, the incorporated a seasonal pattern specifier into the DSM-III-R, allowing for the of recurrent mood disorders with seasonal features, which broadened clinical identification and . Initial investigations in the 1980s focused on small patient cohorts to test interventions, particularly . Rosenthal's 1984 study included preliminary findings from 11 patients exposed to high-intensity light, showing rapid symptom improvement in most cases, suggesting a physiological response to simulated daylight. Subsequent small-scale trials at NIMH and other centers in the mid-1980s replicated these benefits, establishing as an early, effective treatment and spurring further empirical validation of SAD.

Recent Advances and Criticisms

Recent genetic research has highlighted seasonal fluctuations in as a potential contributor to SAD, with studies identifying over 4,000 protein-coding genes that vary seasonally in blood cells and , influencing mood . A 2023 on global prevalence further linked higher latitudes to increased SAD risk, suggesting genetic-environmental interactions play a role in susceptibility. Neuroimaging studies have advanced understanding of light responses in SAD, revealing that seasonal variations in binding in regions like the and predict symptom severity. These findings underscore how diminished winter light exposure alters neural circuits involved in mood, with longitudinal PET imaging showing heightened transporter levels in winter correlating with depressive episodes. A 2025 study published in npj Research examined mobile health data from large cohorts, demonstrating that seasonal depression severity is modulated by weather-induced changes in ; reduced and colder temperatures decreased activity levels, exacerbating symptoms, while improved weather correlated with mood uplift in SAD patients. Critics argue that SAD is often overdiagnosed, mistaking transient "winter blues"—common mild mood dips—for clinical depression, due to self-reporting biases in diagnostic tools like the Seasonal Pattern Assessment Questionnaire. This has led to debates on its , with some experts questioning whether SAD represents a distinct subtype or merely heightened within major depression. Cultural biases influence SAD recognition, as research predominantly from Western, high-latitude populations may overlook variations; for instance, correlates with higher winter-SAD rates, while collectivist societies report lower prevalence and different seasonal patterns. Summer-onset SAD remains underrecognized, comprising only 10-20% of cases but often dismissed amid focus on winter types, potentially due to diagnostic criteria emphasizing fall-winter onsets. Emerging interventions include digital light therapy applications, such as virtual reality-based systems delivering simulated bright light, which a 2025 clinical trial found comparable to traditional light boxes in reducing symptoms by enhancing circadian alignment. Preventive cognitive behavioral therapy (CBT) has gained traction, with a 2025 systematic review and meta-analysis confirming its efficacy in preventing seasonal episodes, equivalent to light therapy in long-term remission rates. Longitudinal cohort studies, such as analyses from the involving 500,000 participants tracked over four years, have illuminated sleep-therapy interactions; winter-specific longer and poorer sleep quality was mitigated by combined light and CBT, reducing depressive recurrence by up to 30%. Key research gaps persist, including limited data from non-Western countries where cultural and climatic factors may alter SAD presentation, as evidenced by lower winter-SAD rates among Sri Lankan and South Asian immigrants compared to Europeans. Additionally, the absence of reliable biomarkers hinders early and personalized treatment, with calls for integrated genetic-neuroimaging approaches to identify objective indicators beyond subjective symptoms.

References

  1. https://www.nimh.nih.gov/health/publications/seasonal-affective-disorder
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6533196/
  3. https://www.ncbi.nlm.nih.gov/books/NBK568745/
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC2686645/
  5. https://www.mayoclinic.org/diseases-conditions/seasonal-affective-disorder/symptoms-causes/syc-20364651
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC4673349/
  7. https://www.mayoclinic.org/diseases-conditions/seasonal-affective-disorder/diagnosis-treatment/drc-20364722
  8. https://pmc.ncbi.nlm.nih.gov/articles/PMC11980904/
  9. https://pmc.ncbi.nlm.nih.gov/articles/PMC5225270/
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC4107419/
  11. https://pmc.ncbi.nlm.nih.gov/articles/PMC2874241/
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC7261710/
  13. https://pubmed.ncbi.nlm.nih.gov/16458365/
  14. https://pubmed.ncbi.nlm.nih.gov/8326080/
  15. https://pubmed.ncbi.nlm.nih.gov/30022319/
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC4019042/
  17. https://pubmed.ncbi.nlm.nih.gov/10572777/
  18. https://pubmed.ncbi.nlm.nih.gov/17546343/
  19. https://pubmed.ncbi.nlm.nih.gov/1773405/
  20. https://www.omicsonline.org/open-access/influence-of-seasonal-affective-disorder-on-immigrant-populations-134936.html
  21. https://www.bch.org/latest-news/2025/july/why-do-i-feel-sad-in-the-summer-recognizing-summ/
  22. https://newsinhealth.nih.gov/2024/11/feeling-sad
  23. https://pmc.ncbi.nlm.nih.gov/articles/PMC6800045/
  24. https://pubmed.ncbi.nlm.nih.gov/2326393/
  25. https://www.cnn.com/2024/01/22/health/sleeping-more-in-winter-research-wellness
  26. https://www.cuimc.columbia.edu/news/how-fight-seasonal-depression
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC10842077/
  28. https://www.theguardian.com/science/2020/dec/20/early-humans-may-have-survived-the-harsh-winters-by-hibernating
  29. https://www.frontiersin.org/news/2023/02/17/humans-dont-hibernate-but-we-still-need-more-winter-sleep/
  30. https://www.nccih.nih.gov/health/seasonal-affective-disorder
  31. https://www.livescience.com/tired-in-winter-the-science-behind-seasonal-fatigue
  32. https://pubmed.ncbi.nlm.nih.gov/10359479/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC3004726/
  34. https://www.hopkinsmedicine.org/health/conditions-and-diseases/seasonal-affective-disorder-what-you-should-know
  35. https://academic.oup.com/book/24578/chapter/187837936
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC5694588/
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC3202495/
  38. https://www.henryford.com/Blog/2021/01/More-Tired-In-Winter
  39. https://www.ncbi.nlm.nih.gov/books/NBK519507/
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC6138666/
  41. https://pubmed.ncbi.nlm.nih.gov/17457720/
  42. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2018.00481/full
  43. https://www.sciencedirect.com/science/article/pii/S0165178124006188
  44. https://www.theguardian.com/society/2025/nov/02/how-to-beat-the-winter-blues-seasonal-affective-disorder
  45. https://academic.oup.com/sleep/article/46/Supplement_1/A285/7182416
  46. https://www.aafp.org/pubs/afp/issues/2020/1201/p668.html
  47. https://www.mrcpsych.uk/2022/05/icd-11criteria-for-symptomatic-and.html
  48. https://www.va.gov/washington-dc-health-care/stories/combating-seasonal-affective-disorder
  49. https://www.mededportal.org/doi/10.15766/mep_2374-8265.9622
  50. https://pubmed.ncbi.nlm.nih.gov/15207934/
  51. https://eprovide.mapi-trust.org/instruments/structured-interview-guide-for-the-hamilton-depression-rating-scale-seasonal-affective-disorders
  52. https://pubmed.ncbi.nlm.nih.gov/1438648/
  53. https://www.psychiatryadvisor.com/features/could-summer-depression-be-seasonal-affective-disorder/
  54. https://pubmed.ncbi.nlm.nih.gov/18849078/
  55. https://pmc.ncbi.nlm.nih.gov/articles/PMC6746555/
  56. https://pmc.ncbi.nlm.nih.gov/articles/PMC9949775/
  57. https://medicine.yale.edu/psychiatry/research/clinics-and-programs/winter-depression/obtain/
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC10800803/
  59. https://www.thecarlatreport.com/articles/3034-a-practical-guide-to-light-therapy
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC3181778/
  61. https://www.researchgate.net/publication/7133659_The_Can-SAD_Study_A_Randomized_Controlled_Trial_of_the_Effectiveness_of_Light_Therapy_and_Fluoxetine_in_Patients_With_Winter_Seasonal_Affective_Disorder
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC3782468/
  63. https://medicine.yale.edu/psychiatry/research/clinics-and-programs/winter-depression/risks/
  64. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2821240
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC12523188/
  66. https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-025-08984-7
  67. https://www.sciencedirect.com/science/article/pii/S002239562400195X
  68. https://www.bmj.com/content/384/bmj-2023-075847
  69. https://psychiatryonline.org/doi/book/10.1176/appi.books.9780890425787
  70. https://pmc.ncbi.nlm.nih.gov/articles/PMC5504611/
  71. https://www.uchicagomedicine.org/forefront/health-and-wellness-articles/2025/april/seasonal-affective-disorder-how-to-spot-and-treat-the-winter-blues
  72. https://health.ucdavis.edu/blog/cultivating-health/seasonal-affective-disorder-winter-blues-and-self-care-tips-to-get-ahead-of-symptoms/2023/11
  73. https://pmc.ncbi.nlm.nih.gov/articles/PMC10175061/
  74. https://pubmed.ncbi.nlm.nih.gov/9395604/
  75. https://www.nature.com/articles/s44184-025-00125-x
  76. https://medlineplus.gov/genetics/condition/seasonal-affective-disorder/
  77. https://www.sciencedirect.com/science/article/abs/pii/S0165032725012492
  78. https://pubmed.ncbi.nlm.nih.gov/16401242/
  79. https://pubmed.ncbi.nlm.nih.gov/10082184/
  80. https://pubmed.ncbi.nlm.nih.gov/20170049/
  81. https://www.psychiatry.org/news-room/news-releases/apa-poll-mood-changes-in-winter
  82. https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-021-03313-z
  83. https://mhanational.org/conditions/seasonal-affective-disorder-sad/
  84. https://healthcare.utah.edu/the-scope/health-library/all/2018/10/seasonal-affective-disorder-affects-women-more-men
  85. https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=85&contentid=p00755
  86. https://www.hopkinsmedicine.org/health/conditions-and-diseases/seasonal-affective-disorder
  87. https://www.ajmc.com/view/what-you-need-to-know-about-seasonal-affective-disorder
  88. https://pubmed.ncbi.nlm.nih.gov/12128248/
  89. https://pmc.ncbi.nlm.nih.gov/articles/PMC12205580/
  90. https://www.jmir.org/2024/1/e55302/
  91. https://thriveworks.com/help-with/research/seasonal-depression-peak/
  92. https://www.omicsonline.org/open-access/influence-of-seasonal-affective-disorder-on-immigrant-populations-2472-0992.1000131.pdf
  93. https://www.scientificarchives.com/article/bipolar-disorders-and-seasonality
  94. https://jdc.jefferson.edu/cgi/viewcontent.cgi?article=1421&context=jeffjpsychiatry
  95. https://jamanetwork.com/journals/jamapsychiatry/article-abstract/493246
  96. https://psychiatryonline.org/doi/10.1176/appi.books.9798894550480.lg02
  97. https://pubmed.ncbi.nlm.nih.gov/6581756/
  98. https://academic.oup.com/brain/article/139/5/1605/2468755
  99. https://journals.sagepub.com/doi/abs/10.1177/2167702615615867
  100. https://pmc.ncbi.nlm.nih.gov/articles/PMC5572284/
  101. https://clinicaltrials.gov/study/NCT07161570
  102. https://www.cambridge.org/core/journals/the-cognitive-behaviour-therapist/article/cognitive-behavioural-therapy-for-seasonal-affective-disorder-a-systematic-review-and-metaanalysis/3BE2F4E82C0D68D50EC0C33A33C41E2D
  103. https://pubmed.ncbi.nlm.nih.gov/23820095/
Add your contribution
Related Hubs
Contribute something
User Avatar
No comments yet.